Ritter Pharmaceuticals' Debt - III Round

Ritter Pharmaceuticals raised a round of funding on February 23, 2012. Investors include Javelin Venture Partners.

Ritter Pharmaceuticals is a specialty pharmaceutical company developing therapeutics based upon colonic adaptation to treat gastrointestinal diseases with an initial focus on lactose intolerance. Colo…

Articles about Ritter Pharmaceuticals' Debt - III Round: